Moreover, ANXA5 has a broad distribution and has been observed to exhibit abnormal expression in various cancer types, such as prostate cancer, cervical carcinoma, and cholangiocarcinoma [60, 61]. This evidence concerns the gene ANXA5 and prostate cancer.